These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 7460040

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Local active immunotherapy for malignant melanoma.
    Serrou B, Dubois JB, Meiss L, Romieu C.
    Panminerva Med; 1975; 17(5-6):182-6. PubMed ID: 1161316
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L, Clark DA.
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
    Henz BM, Macher E, Bröcker EB, Suciu S, Steerenberg PA, Jung E, Rümke P.
    Dermatology; 1996 Dec; 193(2):105-9. PubMed ID: 8884144
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW.
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract] [Full Text] [Related]

  • 33. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ.
    Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Histologic changes in the human skin melanoma after intratumorous treatment with BCG.
    Svejda J, Mechl Z, Sopková B, Foukal T.
    Neoplasma; 1979 Feb; 26(2):215-21. PubMed ID: 471128
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
    Gutterman J, Mavligit G, McBride C, Frei E, Hersh EM.
    Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915
    [No Abstract] [Full Text] [Related]

  • 40. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E.
    Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.